American Well Corp (AMWL) officer reports automatic RSU tax sell-to-cover

Rhea-AI Filing Summary

American Well Corp’s Chief Product & Technology Officer reported a routine tax-related stock sale. On 01/02/2026, the insider sold 6,243 shares of Class A common stock at $4.85 per share. According to the explanation, the sale was an automatic “sell to cover” transaction used to pay taxes arising from the vesting and settlement of restricted stock units on January 1, 2026, and did not represent a discretionary trade.

After this transaction, the reporting person beneficially owned 191,468 shares of American Well Corp stock, held directly.

Insider Trade Summary

Net Seller: 6,243 shares

Net Sell 1 txn

Insider Zamansky Dmitry

Role Chief Product & Tech. Officer

Sold 6,243 shs ($30K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	6,243	$4.85	$30K

Holdings After Transaction: Class A Common Stock — 191,468 shares (Direct)

Footnotes (1)

1. F1. The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on January 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/05/2026 - 05:09 PM Learn about SEC filing dates

FAQ

What insider transaction did American Well Corp (AMWL) report?

The Chief Product & Technology Officer of American Well Corp (AMWL) reported selling 6,243 shares of Class A common stock on 01/02/2026 at $4.85 per share.

Why did the AMWL insider sell 6,243 shares?

The filing states the shares were sold to pay the tax liability from the vesting and settlement of restricted stock units on January 1, 2026 through an automatic “sell to cover” transaction.

Was the American Well Corp (AMWL) insider sale discretionary?

No. The sale was described as an automatic “sell to cover” transaction and the filing notes it did not represent a discretionary trade by the reporting person.

How many American Well (AMWL) shares does the insider hold after the sale?

Following the reported transaction, the Chief Product & Technology Officer beneficially owned 191,468 shares of American Well Corp Class A common stock, held directly.

What role does the reporting person hold at American Well Corp (AMWL)?

The reporting person serves as Chief Product & Technology Officer of American Well Corp.

What type of security was involved in this AMWL Form 4 filing?

The transaction involved Class A common stock of American Well Corp (AMWL). No derivative securities were reported in Table II.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zamansky Dmitry

(Last) (First) (Middle)

C/O 75 STATE STREET

26TH FLOOR

(Street)

BOSTON MA 02109

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
American Well Corp [ AMWL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product & Tech. Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/02/2026		S(1)		6,243	D	$4.85	191,468	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on January 1, 2026. The sales were effected through and automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person

Remarks:

Chief Product & Technology Officer

	/s/ Anna Nesterova as attorney-in-fact for Dmitry Zamansky	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.